© 2021 MJH Life Sciences™ and Managed Healthcare Executive. All rights reserved.
All News
The Controversy Over Omega-3 Fatty Acids
A failed trial at the American Heart Association leads to pointed fingers at game-changing research on Vascepa, and counter claims of "manufactured controversy."
FDA Advisory Panel Votes Against Blanket Booster but for Third Shot for Elderly, Those at High Risk of Severe COVID-19
September 17, 2021
Committee's two votes are only recommendations but a narrower booster emergency use authorization now seems likely.
6 Takeaways From 2021 PBMI Annual National Conference
September 17, 2021
The specialty drug spend and data flow and connectivity were among the themes of the presentations given at the hybrid conference this week in Orlando, Florida.
ICER Foresees AstraZeneca’s Tezepelumab for Severe Asthma As Being Only Modestly Cost Effective
September 17, 2021
Tezepelumab, which is being currently reviewed by the FDA, provides small improvements in daily symptoms and quality of life but is only modestly cost-effectiveness at the anticipated price, according to the cost-effectiveness group's calculations.
AI: Beyond the Buzz
September 17, 2021
Artificial intelligence is improving healthcare methods and insights. But when used incorrectly, AI is rife with pitfalls.
Ibrance Shows Promise in Treatment of Myelofibrosis
September 17, 2021
An Ibrance-Jakafi combination shows promise in a mouse model of myelofibrosis.
Stemming the Rising Tide of Insulin Prices
September 16, 2021
States are putting caps on prices, and Semglee, the first interchangeable biosimilar in the United States, may exert some downward pressure.
Retailers Want to Provide You Healthcare, Not Just Sell you Stuff
September 16, 2021
But CVS, Walgreens and Walmart differ in how they are setting up in-store health clinics.
Jasper Health Wins 1st PBMI Innovation Challenge
September 15, 2021
The new company has developed an app and platform that guides cancer survivors through the experience of dealing with disease.
What “Next Gen” Specialty Drug Cost Management Looks Like
September 15, 2021
CVS’ Joshua Fredell, Pharm.D., and Tierra Ford, Pharm.D., described how an integrated, proactive approach can engage members and rein in costs.
A Patient-Centric Approach: Care Plans for Patients Pay Off
September 15, 2021
Paula Bickley and Ashleigh Burdette of Biologics by McKesson described a program that identifies 1 in 3 patients as being at risk of nonadherence and then provides support to keep them on track and identify side effects and other problems early.